Cell counting market is expected to witness positive growth in future as it has wide range of applications in research institutes, hospitals, biotechnology and pharmaceuticals companies and it an important tool in research, drug discovery and biopharmaceutical applications. Increasing prevalence of cancer and rising geriatric population are major driver for the market growth. Furthermore, factors responsible for the growth of the cell counting market in Asia Pacific are rising awareness regarding prevalence of disease such as cancer and other lifestyle diseases and improvement in healthcare facilities. High cost of cell counting instruments may create an obstacle for the market growth.
Asia-Pacific Cell Counting Market is expected to grow at a CAGR of 10.5% during forecast period 2017 to 2023.
Taste the market data and market information presented through more than 22 market data tables and figures spread over 50 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Cell Counting Market Research Report– Asia Pacific Forecast till 2023.”
Asia-Pacific Cell Counting Market Players:
Key players in cell counting market are Bio-Rad Laboratories Inc. (U.S), General Electric Company (U.S), Agilent Technologies (U.S), PerkinElmer Inc. (U.S), Tecan Trading AG (Switzerland), BioTek Instruments, Inc. (U.S), Danaher (U.S), Merck KGaA (U.S).
The Asia Pacific cell counting market is segmented on the basis on instruments used for cell counting which are spectrophotometer, cell counter, hemocytometer, flow cytometer, hematology analyzer, microscope and other instruments. On the basis of application of cell counting which includes cell structure study and cell analysis, quality control, cell viability, proliferation, signaling, identification, single cell analysis and other applications. It is also segmented on the basis of its end users which are hospitals, research institutes, pharmaceutical and biotechnology companies, clinical research organizations and other end users.
Asia Pacific cell counting market consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia Pacific. Japan is the largest market for cell counting due to an increase in prevalence of cancer and demand for new cell counting techniques.
China and Japan are major manufacturers of medical devices. In China, factors responsible for the market growth are rising geriatric population with chronic diseases, increasing experimental use of cell counting devices, and availability of low cost diagnostic and treatment options.
Rising number of diagnostic centers, growing emphasis of cell counting for the diagnosis of chronic diseases and overall growth of diagnostic services drive the market in India. Lack of awareness about the available diagnostic services also boost the market growth.
Australia and Republic of Korea show slow growth in cell counting market.